56 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; (iv) the recorded … distribution, use, access, disablement, misappropriation or modification, or other compromise or misuse relating to any IT Systems, material
8-K
EX-99.1
c3uenuajof3xfjj
12 Oct 23
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:03pm
8-K
EX-3.1
lk8 bzymr5f7yzc6
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-10.1
1f10v nw3za12q117q
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
39xr84r4anupuf
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
kss9k
8 Jul 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-99.1
27lvbsl
26 May 22
Other Events
7:02am